The expression of the urinary forms of human luteinizing hormone beta fragment in various populations as assessed by a specific immunoradiometric assay.
Human gonadotrophins undergo metabolic transformations which result in the presence of several smaller, structurally and immunologically related forms of gonadotrophins in the urine. For luteinizing hormone (LH), a beta core fragment (LHbeta cf) has been isolated from the pituitary and characterized. The corresponding urinary fragment is inferred from mass spectral and immunochemical analysis of chromatographically separated urinary forms. Physicochemical characteristics, primarily mass spectral and chromatographic, indicate that the pituitary and urinary forms of LHbeta cf have a different structure, probably in the carbohydrate moieties. This communication characterizes the expression of LHbeta cf in the urine of both reproductive and post-reproductive age women and in men, employing assays highly specific for the pituitary form of the fragment. It was found that LHbeta cf is the predominant LH associated molecular form in the urine during peri-ovulatory period, peaking 1-3 days later than intact LH and reaching a concentration of approximately 600 fmol/mg creatinine, 7-fold higher than either LH or LH free beta subunit. Corresponding concentrations of human chorionic gonadotrophin (HCG) beta cf were <1% that of LHbeta cf. LHbeta cf cross-reaction with some LH or LHbeta monoclonal antibodies may well interfere with the accurate estimation of the day of the LH surge when urinary tests are utilized.
O'Connor
J F
JF
Department of Pathology and Irving Center for Clinical Research, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Kovalevskaya
G
G
Birken
S
S
Schlatterer
J P
JP
Schechter
D
D
McMahon
D J
DJ
Canfield
R E
RE
D000293:Adolescent; D000328:Adult; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000652:urine; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D005260:Female; D006801:Humans; D015592:Immunoradiometric Assay / Q000379:methods*; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism / Q000652:urine*; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D010060:Ovulation / Q000097:blood / Q000652:urine; D010446:Peptide Fragments / Q000097:blood / Q000378:metabolism / Q000652:urine*; D010902:Pituitary Gland / Q000378:metabolism; D011863:Radioimmunoassay
D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D007986:Luteinizing Hormone